Jia Kim

Cheongju-si, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Joint Publication of the First 2024-2025 National Influenza Annual Report by the Korea Disease Control and Prevention Agency and the National Health Insurance Service.

Joint Publication of the First 2024-2025 National Influenza Annual Report by the Korea Disease Control and Prevention Agency and the National Health Insurance Service.

Journal: Public health weekly report
Published: May 12, 2026

Influenza Sentinel Surveillance in the Post-coronavirus Disease 2019 Period.

Influenza Sentinel Surveillance in the Post-coronavirus Disease 2019 Period.

Journal: Public health weekly report
Published: December 29, 2025

Effectiveness of Second mRNA COVID-19 Booster Vaccine in Immunocompromised Persons and Long-Term Care Facility Residents.

Effectiveness of Second mRNA COVID-19 Booster Vaccine in Immunocompromised Persons and Long-Term Care Facility Residents.

Journal: Emerging infectious diseases
Published: October 03, 2022

Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study.

Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study.

Journal: Journal of Korean medical science
Published: September 20, 2022

Presumed population immunity to SARS-CoV-2 in South Korea, April 2022.

Presumed population immunity to SARS-CoV-2 in South Korea, April 2022.

Journal: Osong public health and research perspectives
Published: September 15, 2022

Long-term Effectiveness Associated With the BNT162b2 Vaccine Against SARS-CoV-2 Infection Among Adolescents in South Korea.

Long-term Effectiveness Associated With the BNT162b2 Vaccine Against SARS-CoV-2 Infection Among Adolescents in South Korea.

Journal: JAMA network open
Published: August 17, 2022

Effectiveness of Booster mRNA Vaccines Against SARS-CoV-2 Infection in an Elderly Population, South Korea, October 2021-January 2022.

Effectiveness of Booster mRNA Vaccines Against SARS-CoV-2 Infection in an Elderly Population, South Korea, October 2021-January 2022.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 19, 2022

Time from Exposure to Diagnosis among Quarantined Close Contacts of SARS-CoV-2 Omicron Variant Index Case-Patients, South Korea.

Time from Exposure to Diagnosis among Quarantined Close Contacts of SARS-CoV-2 Omicron Variant Index Case-Patients, South Korea.

Journal: Emerging infectious diseases
Published: March 23, 2022

SARS-CoV-2 Breakthrough Infections after introduction of 4 COVID-19 Vaccines, South Korea, 2021.

SARS-CoV-2 Breakthrough Infections after introduction of 4 COVID-19 Vaccines, South Korea, 2021.

Journal: Emerging infectious diseases
Published: February 24, 2022

Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021.

Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021.

Journal: Emerging infectious diseases
Published: February 16, 2022

Impact of national Covid-19 vaccination Campaign, South Korea.

Impact of national Covid-19 vaccination Campaign, South Korea.

Journal: Vaccine
Published: January 11, 2022

Importation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021.

Importation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021.

Journal: Journal of Korean medical science
Published: December 15, 2021
Showing 1-12 of 13

Last Updated: 09/26/2026